Direct binding to antigen-coated beads refines the specificity and cross-reactivity of four monoclonal antibodies that recognize polymorphic epitopes of HLA class I molecules

Tissue Antigens

Volumn 81, Issue 4, 2013, Pages 212-220

  Hilton, H G ^a   Parham, P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epitope; Human leukocyte antigen class I; Monoclonal antibodies; Polymorphism

Indexed keywords

CROSS REACTING ANTIBODY; EPITOPE; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; HLA C ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BB7.1; MONOCLONAL ANTIBODY BB7.2; MONOCLONAL ANTIBODY MA2.1; MONOCLONAL ANTIBODY PA2.1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ANTIGENIC VARIATION; ARTICLE; CONTROLLED STUDY; CROSS REACTION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CROSS REACTIONS; EPITOPES; HLA ANTIGENS; HUMANS; IMMOBILIZED PROTEINS; MICROSPHERES; MOLECULAR DOCKING SIMULATION; MOLECULAR SEQUENCE DATA; PROTEIN BINDING;

EID: 84875547665     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/tan.12095     Document Type: Article

References (38)

1. Barnstable CJ, Bodmer WF, Brown G et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell 1978: 14: 9-20.
2. Brodsky FM, Parham P, Barnstable CJ, Crumpton MJ, Bodmer WF. Monoclonal antibodies for analysis of the HLA system. Immunol Rev 1979: 47: 3-61.
3. Parham P, Bodmer WF. Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature 1978: 276: 397-9.
4. Parham P, Brodsky FM. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28. Hum Immunol 1981: 3: 277-99.
5. Holmes N, Parham P. Exon shuffling in vivo can generate novel HLA class I molecules. EMBO J 1985: 4: 2849-54.
6. Parham P, Antonelli P, Herzenberg LA, Kipps TJ, Fuller A, Ward FE. Further studies on the epitopes of HLA-B7 defined by murine monoclonal antibodies. Hum Immunol 1986: 15: 44-67.
7. Parham P, Lomen CE, Lawlor DA et al. Nature of polymorphism in HLA-A, -B, and -C molecules. Proc Natl Acad Sci U S A 1988: 85: 4005-9.
8. Cao K, Hollenbach J, Shi X, Shi W, Chopek M, Fernandez-Vina MA. Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations. Hum Immunol 2001: 62: 1009-30.
9. McMichael AJ, Parham P, Rust N, Brodsky F. A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17. Hum Immunol 1980: 1: 121-9.
10. Ways JP, Parham P. The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2. Biochem J 1983: 216: 423-32.
11. Shimizu Y, Koller B, Geraghty D et al. Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells. Mol Cell Biol 1986: 6: 1074-87.
12. Pei R, Lee JH, Shih NJ, Chen M, Terasaki PI. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003: 75: 43-9.
13. El-Awar N, Lee J, Terasaki PI. HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol 2005: 66: 989-97.
14. Moesta AK, Norman PJ, Yawata M, Yawata N, Gleimer M, Parham P. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J Immunol 2008: 180: 3969-79.
15. Hilton HG, Vago L, Older Aguilar AM et al. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3. J Immunol 2012: 189: 1418-30.
16. Taketani S, Krangel MS, Pious D, Strominger JL. Structural analysis of HLA-A2 antigen from immunoselected mutant 8.6.1: further definition of an HLA-A2-specific serological determinant. J Immunol 1983: 131: 2935-8.
17. Ways JP, Rothbard JB, Parham P. Amino acid residues 56 to 69 of HLA-A2 specify an antigenic determinant shared by HLA-A2 and HLA-B17. J Immunol 1986: 137: 217-22.
18. Salter RD, Clayberger C, Lomen CE, Krensky AM, Parham P. In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA molecule. J Exp Med 1987: 166: 283-8.
19. Santos-Aguado J, Barbosa JA, Biro PA, Strominger JL. Molecular characterization of serologic recognition sites in the human HLA-A2 molecule. J Immunol 1988: 141: 2811-8.
20. Hogan KT, Clayberger C, Bernhard EJ et al. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes. J Immunol 1989: 142: 2097-104.
21. Fuller AA, Trevithick JE, Rodey GE, Parham P, Fuller TC. Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes. Hum Immunol 1990: 28: 284-305.
22. Lombardi G, Matsui M, Moots R et al. Limited regions of the alpha 2-domain alpha-helix control anti-A2 allorecognition: an analysis using a panel of A2 mutants. Immunogenetics 1991: 34: 149-56.
23. Hogan KT, Brown SL. Localization and characterization of serologic epitopes on HLA-A2. Hum Immunol 1992: 33: 185-92.
24. Barouch D, Davenport M, McMichael A, Reay P. A mAb against HLA-A2 can be influenced both positively and negatively by the associated peptide. Int Immunol 1995: 7: 1599-605.
25. Parham P. Antigenic determinants of the HLA-B7 molecule; Bw6- and B7-specific determinants are spatially separate. Immunogenetics 1983: 18: 1-16.
26. Wan AM, Ennis P, Parham P, Holmes N. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes. J Immunol 1986: 137: 3671-4.
27. Toubert A, Raffoux C, Boretto J et al. Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants. J Immunol 1988: 141: 2503-9.
28. Domenech N, Santos-Aguado J, Lopez de Castro JA. Antigenicity of HLA-A2 and HLA-B7. Loss and gain of serologic determinants induced by site-specific mutagenesis at residues 62 to 80. Hum Immunol 1991: 30: 140-6.
29. McCutcheon JA, Lutz CT. Mutagenesis around residue 176 on HLA-B*0702 characterizes multiple distinct epitopes for anti-HLA antibodies. Hum Immunol 1992: 35: 125-31.
30. McCutcheon JA, Smith KD, Valenzuela A, Aalbers K, Lutz CT. HLA-B*0702 antibody epitopes are affected indirectly by distant antigen residues. Hum Immunol 1993: 36: 69-75.
31. Parham P, Barnstable CJ, Bodmer WF. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C, antigens. J Immunol 1979: 123: 342-9.
32. Svejgaard A, Kissmeyer-Nielsen F. Cross-reactive human HL-A isoantibodies. Nature 1968: 219: 868-9.
33. Mizuno S, Yako F, Ohta H et al. A new murine lymphocytotoxic monoclonal antibody recognizing HLA-A2, -A28 and -A9. Tissue Antigens 1996: 48: 224-7.
34. Little AM, Madrigal JA, Parham P. Molecular definition of an elusive third HLA-A9 molecule: HLA-A9.3. Immunogenetics 1992: 35: 41-5.
35. Ellexson ME, Zhang G, Stewart D et al. Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant alpha-helical motifs produce complex serologic recognition patterns for the HLA-B"DT" and HLA-B"NM5" antigens. Hum Immunol 1995: 44: 103-10.
36. Vilches C, Sanz L, de Pablo R, Moreno ME, Puente S, Kreisler M. Molecular characterization of the new alleles HLA-B*8101 and B*4407. Tissue Antigens 1996: 47: 139-42.
37. Bergmans AM, Tijssen H, Lardy N, Reekers P. Complete nucleotide sequence of HLA-B*0703, a B7 variant (BPOT). Hum Immunol 1993: 38: 159-62.
38. Zemmour J, Parham P. Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C. J Exp Med 1992: 176: 937-50.